γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study intends to combine the advantages of γδ T cells and PD-1 monoclonal antibody to conduct an exploratory clinical study on the safety and efficacy of PD-1 antibody armored γδ T cells (γδ T-PD-1 Ab cells) in the treatment of malignant meningioma.
Epistemonikos ID: 8153fcc0fa0fd728defde4572a5e30116453a49e
First added on: Sep 16, 2025